Prolactin is an autocrine or paracrine growth factor for human myometrial and leiomyoma cells

R A Nowak, Romana A. Nowak, S Mora, Samia Mora, Thekla S. Diehl, T Diehl, A R Rhoades, Alan R. Rhoades, E A Stewart, Elizabeth A. Stewart
Gynecologic and obstetric investigation · 1999 · vol. 48(2) , pp. 127–132 · doi:10.1159/000010154 · PMID:10461005 · W2071457523
Lab / animal OA: closed CC0 ⤵ 11 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-06 ⓘ

Prolactin was found to promote growth of human myometrial and leiomyoma cells through autocrine or paracrine signaling via its receptor.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To test the hypothesis that prolactin (PRL) acts as a mitogenic growth factor for human leiomyoma and myometrial cells. METHODS: To test this hypothesis, we performed three different types of experiments. First, we assessed whether exogenous PRL acted as a mitogen for cultured uterine smooth muscle cells. Second, we examined the role of endogenous PRL by assessing the cell number after exposure of the cultures to a neutralizing antibody to PRL. Finally, we examined both fresh tissues and cultured cells for expression of the PRL receptor messenger ribonucleic acid using the techniques of reverse-transcriptase polymerase chain reaction and Southern blotting. RESULTS: A significant suppression in cell number was seen after 5 days of culture for leiomyoma cells but not for myometrial cells after treatment with exogenous PRL. Both cell types showed a significant decrease in cell number after treatment with anti-PRL antibody. A 893-bp segment consistent with the cytoplasmic domain of the long form of the PRL receptor was amplified from both fresh and cultured tissues and confirmed by Southern blotting and sequencing. CONCLUSIONS: PRL appears to be an autocrine or paracrine growth factor for both leiomyoma and myometrial cells. However, there are some differences between tissues in their sensitivity to this growth factor.

My notes (saved in your browser only)

MeSH descriptors

Autocrine Communication Growth Substances Leiomyoma Myometrium Paracrine Communication Prolactin Uterine Neoplasms Antibodies Antibodies Autocrine Communication Blotting, Southern Cell Count Cell Division DNA DNA DNA Female Growth Substances Humans Immunoenzyme Techniques

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (19)

Cited by (9)

Source provenance

openalex
last seen: 2026-05-11T06:35:44.859312+00:00
pubmed
last seen: 2026-10-08T20:59:07.345995+00:00
unpaywall
last seen: 2026-10-16T06:24:35.758740+00:00
License: CC0 · commercial use OK